Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
Dow
Moodys
Harvard Business School

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Eurohlth Intl Sarl Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for EUROHLTH INTL SARL, and what generic and branded alternatives to EUROHLTH INTL SARL drugs are available?

EUROHLTH INTL SARL has thirteen approved drugs.



Summary for Eurohlth Intl Sarl
US Patents:0
Tradenames:10
Ingredients:9
NDAs:13

Drugs and US Patents for Eurohlth Intl Sarl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eurohlth Intl Sarl NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 071287-001 May 24, 1988 DISCN No No   Start Trial   Start Trial
Eurohlth Intl Sarl ACYCLOVIR IN SODIUM CHLORIDE 0.9% PRESERVATIVE FREE acyclovir sodium INJECTABLE;INJECTION 074885-002 Dec 19, 1997 DISCN No No   Start Trial   Start Trial
Eurohlth Intl Sarl NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 071274-001 May 24, 1988 DISCN No No   Start Trial   Start Trial
Eurohlth Intl Sarl NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 071273-001 May 24, 1988 DISCN No No   Start Trial   Start Trial
Eurohlth Intl Sarl MORPHINE SULFATE morphine sulfate INJECTABLE;INJECTION 205758-001 May 21, 2015 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Baxter
Boehringer Ingelheim
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.